Pablo Menéndez Bujan

Scientific Director (Campus Clinic) / ICREA Research Professor

Josep Carreras Leukaemia Research Institute

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Pablo Menéndez Bujan serves as the Scientific Director at Campus Clinic and is an ICREA Research Professor at the Josep Carreras Leukaemia Research Institute in Spain. His research primarily focuses on acute leukemias and the epigenetic mechanisms underlying hematological malignancies, as evidenced by his recent publications on KMT2A recombinome and aberrant DNA methylation in GATA2 deficiency. Additionally, his work explores innovative therapeutic strategies for T cell acute lymphoblastic leukemia and CAR T cell therapies.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (6)

Thomas Burmeister

Charité Universitätsmedizin Berlin - Campus Virchow-Klinikum

GERMANY

View details

Alessandra Giorgetti

Universitat Autònoma de Barcelona Facultat de Medicina

SPAIN

View details

Cedric Ghevaert

Senior Lecturer in Transfusion Medicine

University of Cambridge

UNITED KINGDOM

View details

Oscar Molina

SPAIN

View details

Simon Bomken

Newcastle University

UNITED KINGDOM

View details

Carolina Martínez-Laperche

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Pablo Menéndez Bujan

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

The KMT2A recombinome of acute leukemias in 2023.

Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency.

TIM3, a human acute myeloid leukemia stem cell marker, does not enrich for leukemia-initiating stem cells in B-cell acute lymphoblastic leukemia.

Low input capture Hi-C (liCHi-C) identifies promoter-enhancer interactions at high-resolution.

A Blueprint for Success: Implementation of the Center for Medicare and Medicaid Services Mandated Anesthesiology Oversight for Procedural Sedation in a Large Health System

A new T cell-redirecting strategy for the treatment of relapse/refractory T cell acute lymphoblastic leukemia

A novel and efficient tandem CD19-and CD22-directed CAR for B cell ALL

A single-cell expression atlas of human AML-LScs unravels the contribution of HIF pathway and its therapeutic potential

ABO gene editing for the conversion of blood type A to universal type O in Rh-null donor-derived human-induced pluripotent stem cells

Adaptive monitoring of coral health at Scott Reef where data exhibit nonlinear and disturbed trends over time

Collaborators (6)

Thomas Burmeister

Alessandra Giorgetti

Cedric Ghevaert

Oscar Molina

Simon Bomken

Carolina Martínez-Laperche

Make your next move.